HK2 and Insulin resistance: To counter peripheral insulin resistance, we seek to inhibit HK2-mediated glucose metabolism in the skeletal muscle and adipose tissue in the fasting phase but not in the absorptive phase; therefore, direct chemical inhibitors of HK2 are undesirable.